PT Hetzer Medical Indonesia Tbk (IDX:MEDS)
Indonesia · Delayed Price · Currency is IDR 74.00
-1.00 (-1.33%)
Sep 2, 2026, 2:17 PM WIB
IDX:MEDS Revenue
PT Hetzer Medical Indonesia Tbk had revenue of 6.77B IDR in the quarter ending June 30, 2026, with 405.51% growth. This brings the company's revenue in the last twelve months to 15.01B, up 265.87% year-over-year. In the year 2025, PT Hetzer Medical Indonesia Tbk had annual revenue of 6.63B with 3.73% growth.
Revenue (ttm)
15.01B
Revenue Growth
+265.87%
P/S Ratio
7.81
Revenue / Employee
n/a
Employees
18
Market Cap
117.19B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.63B | 238.07M | 3.73% |
| Dec 31, 2024 | 6.39B | -16.33B | -71.87% |
| Dec 31, 2023 | 22.72B | -15.01B | -39.79% |
| Dec 31, 2022 | 37.74B | -38.05B | -50.21% |
| Dec 31, 2021 | 75.79B | -12.00B | -13.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 37.72T |
| PT Siloam International Hospitals Tbk | 13.51T |
| PT Mitra Keluarga Karyasehat Tbk | 5.57T |
| PT Millennium Pharmacon International Tbk | 4.30T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.70T |
| PT Phapros Tbk | 965.50B |
| PT Ikapharmindo Putramas Tbk | 400.25B |
| PT Nanotech Indonesia Global Tbk | 237.83B |